The CCL2–CCR2 Axis Contributes to Migration of Cabazitaxel-resistant Prostate Cancer Cells
Sign Up to like & getrecommendations! Published in 2023 at "AntiCancer Research"
DOI: 10.21873/anticanres.16423
Abstract: Background/Aim: Developing resistance to cabazitaxel is a major challenge in patients with docetaxel- and castration-resistant prostate cancer (CRPC) since it is frequently administered as a last resort. We have previously reported that CCL2 induces resistance… read more here.
Keywords: cabazitaxel; du145 txr; txr; txr cxr ... See more keywords